• Home
  • Blog

Call us today! +1 (352) 353-0052

Find our Location
info@derivatixcapital.com
Login

Login
Derivatix Capital ManagementDerivatix Capital Management
  • Home
  • Blog

Derivatix quarterly report: Q1-2017 as of Mar. 31, 2017

Home UncategorizedDerivatix quarterly report: Q1-2017 as of Mar. 31, 2017

Derivatix quarterly report: Q1-2017 as of Mar. 31, 2017

March 31, 2017 Uncategorized
1. Since the overall US market kept its directional move upward, we experienced a challenging first quarter in 2017. That is not a perfect condition for our trading strategy so we preferred to be safe and preserve the capital rather than risking it to make large profits.
2. We finished this quarter with a moderate 2.72% net profit which helped us to land on above 60% net profit since inception.

Picture

3. Compared to major US market indices, Derivatix’s long term performance well exceed these benchmarks. Since the fund inception, S&P500 had 19%, Dow Jones 25% and NASDAQ 27% growth meanwhile (Blue bars below). As the market returns to its normal volatility, we expect to gain even more in upcoming quarters.
4. Derivatix received more capital from its existing and new investors at the end of Q1-2017. The fund is now more than 3.5 time larger as of AUM (Asset Under Management) compare to a year ago and is on its sound path to continue its progress throughout 2017.
5. We are very delighted to announce that Derivatix is getting into an agreement with some local financial institutes to extend educational, advisory and fund management services to emerging oversees stock exchanges on Options. Further news in this regard will be announced here later.
6. More update on Derivatix progress in Q2-2017 and upcoming info sessions and educational seminars will come in few days.
7. Stay tuned!

Share
0

You also might be interested in

Derivatix monthly report: Month 28 as of Dec. 31, 2017

Jan 23, 2018

What a year! For the first time, the S&P 500[...]

Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021

Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021

Apr 15, 2021

2020-Q4 Market Summary*: Efficient U.S. vaccination distribution, $1.9 trillion in[...]

Derivatix Quarterly Report: 2019-Q3 as of Sep. 30st, 2019

Derivatix Quarterly Report: 2019-Q3 as of Sep. 30st, 2019

Oct 17, 2019

The amazing fall season is here. Enjoy it before it[...]

Leave a Reply

Your email is safe with us.
Cancel Reply

You must be logged in to post a comment.

Recent Posts

  • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
  • Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
  • Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021
  • Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021
  • Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021
  • Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021
  • Derivatix Info Session Mar. 7th 2021
  • Derivatix Quarterly Report: 2020-Q4 as of Dec. 31st, 2020

Recent Comments

    Archives

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent Comments

    Find us on

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Send Message

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.

    Contact Info

    • Derivatix Capital Management
    • 639 Bird Road, Coral Gables, Florida, 33146, USA
    • +1 (352) 353-0052
    • info@derivatixcapital.com
    • derivatixcapital.com

    Fresh from blog

    • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
    • Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
    • Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021
    • Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021
    • Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021
    • Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021

    © 2022 — Derivatix Capital Management.

    • Home
    • Blog
    Prev Next

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.